Membranous nephropathy

518,479views

Membranous nephropathy

MOD1

MOD1

T-cell development
T-cell activation
Antibody classes
Cell-mediated immunity of natural killer and CD8 cells
B- and T-cell memory
B-cell activation, differentiation, and contraction
B-cell development
Inflammation
Wound healing
VDJ rearrangement
Somatic hypermutation and affinity maturation
MHC class I and MHC class II molecules
Cell-mediated immunity of CD4 cells
Introduction to the immune system
Complement system
Metaplasia and dysplasia
Necrosis and apoptosis
Contracting the immune response and peripheral tolerance
Innate immune system
Abscesses
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Bacterial structure and functions
Viral structure and functions
Candida
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
COVID-19 mutant variants and herd immunity
Development of the COVID-19 vaccine
Dr. Tom Frieden: Former Director of the CDC (Raise the Line)
Incidence and prevalence
Prevention
Vaccinations: Clinical
COVID-19 vaccine hesitancy
Flatten the curve, raise the line music video
DALY and QALY
Hand hygiene (for nursing assistant training)
Types of personal protective equipment (for nursing assistant training)
Standard and transmission-based precautions (for nursing assistant training)
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Non-steroidal anti-inflammatory drugs
Lupus nephritis
IgA nephropathy (NORD)
Myasthenia gravis
Membranous nephropathy
Rheumatoid arthritis
Vasculitis
Vasculitis: Pathology review
Systemic lupus erythematosus (SLE): Clinical
Renal system anatomy and physiology
Kidney histology
Rapidly progressive glomerulonephritis
Sjogren syndrome
Graves disease
Bullous pemphigoid
Asthma
Systemic lupus erythematosus
Goodpasture syndrome
Acetaminophen (Paracetamol)
Glucocorticoids
Complement deficiency
Atopic dermatitis
Erythema multiforme
Non-corticosteroid immunosuppressants and immunotherapies
BK virus (Hemorrhagic cystitis)
Transplant rejection

Flashcards

Membranous nephropathy

0 of 10 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 52-year-old female comes to the primary care PA due to worsening weight gain. She has gained approximately 20 lbs over the past six weeks. In addition, the patient has been experiencing lower extremity edema and has noticed her urine appears more cloudy than usual. Past medical history is notable for hypertension and hyperlipidemia. Temperature is 37.3°C (99.1°F), pulse is 76/min, respirations are 18/min, blood pressure is 137/84 mmHg, and O2 saturation is 97% on room air. Physical exam is notable for bilateral pitting edema of the lower extremities. A urinalysis is notable for 4+ protein (reference range: none) and oval fat bodies but no hematuria. A renal biopsy is performed, and light microscopy demonstrates diffuse capillary and glomerular basement membrane thickening, as shown below:


Reproduced from: Wikipedia

Which of the following is most suggestive of this patient’s underlying diagnosis?

Transcript

Watch video only

Content Reviewers

Membranous glomerulonephritis, also known as membranous nephropathy, is where the glomerular basement membrane, or GBM, which lines the glomeruli in the kidney, becomes inflamed and damaged, which results in increased permeability and proteins being able to filter through into the urine, causing nephrotic syndrome.

But what exactly is nephrotic syndrome? Well usually the glomerulus only lets small molecules, like sodium and water, move from the blood into the kidney nephron, where it eventually makes its way into the urine. But with nephrotic syndromes, the glomeruli are damaged and they become more permeable, so they start letting plasma proteins come across from the blood to the nephron and then into the urine, which causes proteinuria, typically greater than 3.5 grams per day.

An important protein in the blood is albumin, and so when it starts leaving the blood, people get hypoalbuminemia—low albumin in the blood.

With less protein in the blood the oncotic pressure falls, which lowers the overall osmotic pressure, which drives water out of the blood vessels and into the tissues, called edema.

Finally, it’s thought that as a result of either losing albumin or losing some protein or proteins that inhibit the synthesis of lipids, or fat, you get increased levels of lipid in the blood, called hyperlipidemia.

Just like the proteins, these lipids can also get into the urine, causing hyperlipiduria.

And those are the hallmarks of nephrotic syndrome—proteinuria, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.

Alright, so with membranous glomerulonephritis, the basement membrane becomes damaged which causes nephrotic syndrome. How does this happen, though? Well, ultimately this damage is caused by immune complexes—complexes composed of an antigen with an antibody bound to it.

One way these complexes can form is as a result of autoantibodies directly targeting the glomerular basement membrane.

Two major antigen targets that’ve been identified are the M-type phospholipase A2 receptor and neutral endopeptidase, which are both expressed on the podocyte surface—the cells that line the basement membrane, and we know this because a large proportion of cases, people with membranous glomerulonephritis have antibodies against these autoantigens in their bloodstream.

Immune complexes, though, might also form outside of the kidney, and then get carried through the bloodstream to the glomerulus and deposit in the basement membrane.

One potential circulating antigen that’s been identified is cationic bovine serum albumin, which is present in cow’s milk and beef protein, and can escape the intestinal barrier, cause immune complex formation, and deposit in the GBM.

Whether they bind directly to the GBM, or come from somewhere else, these immune complexes are called subepithelial deposits because they’re sandwiched right between the epithelial cells or podocytes, and the GBM.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Membranous nephropathy in children: clinical presentation and therapeutic approach" Pediatric Nephrology (2009)
  6. "Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy" New England Journal of Medicine (2014)
  7. "Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome" Cochrane Database of Systematic Reviews (2014)
  8. "Membranous Glomerulopathy: Emphasis on Secondary Forms and Disease Variants" Advances in Anatomic Pathology (2001)